Blood Cancer United (FKA the Leukemia & Lymphoma Society)

Based in DC

🤖

AI Overview

With $6.8M in lobbying spend across 32 quarterly filings, Blood Cancer United (FKA the Leukemia & Lymphoma Society) is one of the biggest lobbying spenders in Washington. Their lobbying covers 8 issue areas. Active from 2018 to 2025.

$6.8M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$405K
2019	$490K
2020	$420K
2021	$635K
2022	$700K
2023	$1.2M
2024	$1.0M
2025	$1.9M

Issues Lobbied

Medicare/Medicaid Budget/Appropriations Health Issues Education Taxation Unemployment Financial MED

Lobbying Firms

Blood Cancer United (FKA the Leukemia & Lymphoma Society)

Lobbyists

Brian Connell Sarah Milberg Katie Berge Matthew Marks Beverly Hart Jessica Burnell

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Health Issues, Education, Taxation and 3 more

•Medicare Part D plan benefit design and out-of-pocket costs; Part D protected classes protection

•Fiscal Year 2018 National Institutes of Health appropriations; Fiscal Year 2019 National Institutes of Health appropriations; Fiscal Year 2018 Department of Defense appropriations; Fiscal Year 2019 De

•Cancer Drug Parity Act (HR 1409, Senate bill not yet introduced); the Right to Try Act (S 204, HR 878); the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 20